Ning Xie
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Noncanonical functions of UGT2B17 promote castration-resistant prostate cancer progression.
Journal: The Journal of clinical investigation
Published: June 10, 2025
EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathway.
Journal: The Journal of clinical investigation
Published: May 20, 2025
Corrigendum to "RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression" [Eur. Urol. 76(2) (2019) 157-166].
Journal: European urology
Published: May 08, 2025
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression.
Journal: Endocrine-related cancer
Published: April 18, 2025
Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression.
Journal: Oncotarget
Published: February 13, 2025
Retraction: AR-v7 protein expression is regulated by protein kinase and phosphatase.
Journal: Oncotarget
Published: January 20, 2025
Developing novel Lin28 inhibitors by computer aided drug design.
Journal: Cell death discovery
Published: July 15, 2024
PDIA2 has a dual function in promoting androgen deprivation therapy induced venous thrombosis events and castrate resistant prostate cancer progression.
Journal: Oncogene
Published: November 29, 2023
Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness.
Journal: Cancers
Published: September 26, 2022
Freddie: annotation-independent detection and discovery of transcriptomic alternative splicing isoforms using long-read sequencing.
Journal: Nucleic acids research
Published: July 19, 2022
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
Journal: Nature communications
Published: February 06, 2022
Last Updated: 09/26/2026